Lehar Footwears Regulatory Approval

Board Meeting Date

Lehar Footwears Board Meeting Date

Lehar Footwears intimated a Board Meeting scheduled for 02 November 2026. The meeting will consider un-audited financial results for the quarter and half-year ended 30 September 2026.

Other Announcement

Lehar Footwears Other Announcement

Lehar Footwears Ltd has filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the period ended September 30, 2026.

Credit Rating

Lehar Footwears Credit Rating

CRISIL Ratings has reaffirmed the credit ratings for Lehar Footwears Limited's bank loan facilities of Rs.105 Crore, which was enhanced from Rs.78 Crore.

Value

₹105.0 Cr

Business Update

Lehar Footwears Business Update

Lehar Footwears appoints Rajkummar Rao as brand ambassador for its athleisure brand Rannr. The association will drive campaigns across digital, print, and offline channels.

Annual General Meeting

Lehar Footwears Annual General Meeting

Lehar Footwears held its 32nd AGM on September 10, 2026. Resolutions include a final dividend of Rs. 0.50 per share for FY25-26.

Production Started

Lehar Footwears Production Started

Lehar Footwears Limited has commenced operations at its new sports footwear facility in Kundli, Haryana. The expansion increases capacity from 1 lakh to 2.5 lakh pairs per month.

sports footwear capacity

2.5 lakh pairs per month

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.